Apotheek D'HEER Pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek D'HEER Pharma
Largest movements
- Deferred charges and accrued income +€22,616
up €22,616 (+56.2%), from €40,216 to €62,832
- Cash -€19,280
down €19,280 (-47.9%), from €40,284 to €21,004
mainly Deferred charges and accrued income (-€22,616) and Debts after one year (-€15,654)
- Stocks and contracts -€14,617
down €14,617 (-10.9%), from €133,832 to €119,215
- Tangible fixed assets -€13,927
down €13,927 (-11.4%), from €122,088 to €108,161
of which Land and buildings: -€12,062
- Trade debts +€19,577
up €19,577 (+30.1%), from €64,983 to €84,559
- Debts after one year -€15,654
down €15,654 (-9.4%), from €166,727 to €151,072
- Accrued charges and deferred income -€11,490
down €11,490 (-67.0%), from €17,142 to €5,652
- Tax, wage and social debts -€9,047
down €9,047 (-46.1%), from €19,621 to €10,574
of which Remuneration and social security: -€9,872
- Gross operating margin -€66,724
down €66,724 (-39.6%), from €168,527 to €101,803
- Staff costs -€61,749
down €61,749 (-42.6%), from €144,934 to €83,185
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €578,735 | €563,573 | -€15,162 | -2.6% |
| Fixed assets | 21/28 | €122,088 | €108,161 | -€13,927 | -11.4% |
| Tangible fixed assets | 22/27 | €122,088 | €108,161 | -€13,927 | -11.4% |
| Land and buildings | 22 | €118,511 | €106,450 | -€12,062 | -10.2% |
| Plant, machinery and equipment | 23 | €239 | €0 | -€239 | -100% |
| Furniture and vehicles | 24 | €3,337 | €1,711 | -€1,626 | -48.7% |
| Current assets | 29/58 | €456,647 | €455,412 | -€1,235 | -0.3% |
| Amounts receivable after more than one year | 29 | €232,388 | €237,108 | +€4,721 | +2.0% |
| Other amounts receivable | 291 | €232,388 | €237,108 | +€4,721 | +2.0% |
| Stocks and contracts in progress | 3 | €133,832 | €119,215 | -€14,617 | -10.9% |
| Stocks | 30/36 | €133,832 | €119,215 | -€14,617 | -10.9% |
| Amounts receivable within one year | 40/41 | €9,927 | €15,252 | +€5,325 | +53.6% |
| Trade receivables | 40 | €6,700 | €8,556 | +€1,857 | +27.7% |
| Other amounts receivable | 41 | €3,227 | €6,696 | +€3,469 | +107% |
| Cash at bank and in hand | 54/58 | €40,284 | €21,004 | -€19,280 | -47.9% |
| Deferred charges and accrued income | 490/1 | €40,216 | €62,832 | +€22,616 | +56.2% |
| Total equity and liabilities | 10/49 | €578,735 | €563,573 | -€15,162 | -2.6% |
| Equity | 10/15 | €168,871 | €170,028 | +€1,157 | +0.7% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €156,471 | €157,628 | +€1,157 | +0.7% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Tax-exempt reserves | 132 | €202 | €202 | = | 0.0% |
| Distributable reserves | 133 | €154,410 | €155,567 | +€1,157 | +0.7% |
| Amounts payable | 17/49 | €409,864 | €393,545 | -€16,319 | -4.0% |
| Amounts payable after more than one year | 17 | €166,727 | €151,072 | -€15,654 | -9.4% |
| Financial debts | 170/4 | €166,727 | €151,072 | -€15,654 | -9.4% |
| Amounts payable within one year | 42/48 | €225,995 | €236,821 | +€10,825 | +4.8% |
| Current portion of amounts payable after more than one year | 42 | €15,409 | €15,654 | +€245 | +1.6% |
| Financial debts | 43 | €125,000 | €125,000 | = | 0.0% |
| Credit institutions | 430/8 | €125,000 | €125,000 | = | 0.0% |
| Trade debts | 44 | €64,983 | €84,559 | +€19,577 | +30.1% |
| Suppliers | 440/4 | €64,983 | €84,559 | +€19,577 | +30.1% |
| Taxes, remuneration and social security | 45 | €19,621 | €10,574 | -€9,047 | -46.1% |
| Taxes | 450/3 | €21 | €846 | +€825 | +3,961% |
| Remuneration and social security | 454/9 | €19,600 | €9,728 | -€9,872 | -50.4% |
| Other amounts payable | 47/48 | €983 | €1,033 | +€50 | +5.1% |
| Accrued charges and deferred income | 492/3 | €17,142 | €5,652 | -€11,490 | -67.0% |
| Remuneration, social security and pensions | 62 | €144,934 | €83,185 | -€61,749 | -42.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,423 | €13,927 | -€496 | -3.4% |
| Other operating charges | 640/8 | €1,957 | €2,013 | +€56 | +2.9% |
| Gross operating margin | 9900 | €168,527 | €101,803 | -€66,724 | -39.6% |
| Operating profit (loss) | 9901 | €7,213 | €2,678 | -€4,535 | -62.9% |
| Financial income | 75/76B | €9,032 | €9,722 | +€690 | +7.6% |
| Recurring financial income | 75 | €9,032 | €9,722 | +€690 | +7.6% |
| Financial charges | 65/66B | €10,968 | €10,419 | -€548 | -5.0% |
| Recurring financial charges | 65 | €10,968 | €10,419 | -€548 | -5.0% |
| Profit (loss) for the period before taxes | 9903 | €5,277 | €1,982 | -€3,296 | -62.5% |
| Income taxes | 67/77 | €1,362 | €825 | -€537 | -39.4% |
| Profit (loss) for the period | 9904 | €3,916 | €1,157 | -€2,759 | -70.5% |
| Profit (loss) for the period to be appropriated | 9905 | €3,916 | €1,157 | -€2,759 | -70.5% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.